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Cells maintain intracellular pH (pHi) within a narrow range (7.1–7.2) by controlling
membrane proton pumps and transporters whose activity is set by intra-cytoplasmic
pH sensors. These sensors have the ability to recognize and induce cellular responses
to maintain the pHi, often at the expense of acidifying the extracellular pH. In turn,
extracellular acidification impacts cells via specific acid-sensing ion channels (ASICs) and
proton-sensing G-protein coupled receptors (GPCRs). In this review, we will discuss some
of the major players in proton sensing at the plasma membrane and their downstream
consequences in cancer cells and how these pH-mediated changes affect processes such
as migration and metastasis. The complex mechanisms by which they transduce acid
pH signals to the cytoplasm and nucleus are not well understood. However, there is
evidence that expression of proton-sensing GPCRs such as GPR4, TDAG8, and OGR1
can regulate aspects of tumorigenesis and invasion, including cofilin and talin regulated
actin (de-)polymerization. Major mechanisms for maintenance of pHi homeostasis include
monocarboxylate, bicarbonate, and proton transporters. Notably, there is little evidence
suggesting a link between their activities and those of the extracellular H+-sensors,
suggesting a mechanistic disconnect between intra- and extracellular pH. Understanding
the mechanisms of pH sensing and regulation may lead to novel and informed therapeutic
strategies that can target acidosis, a common physical hallmark of solid tumors.
Keywords: proton sensors, pH regulators, cancer microenvironment, buffer therapy, extracellular acidification, and
intracellular pH
ACIDOSIS AND pH REGULATION IN CANCER CELLS
The physical microenvironment of solid tumors is heterogeneous.
A combination of poor vascular perfusion, regional hypoxia,
and increased flux of carbons through fermentative glycolysis
leads to extracellular acidosis in solid tumors; with extracellular
pH (pHe) values as low as 6.5 (Hashim et al., 2011). Notably,
environmental acidification initially occurs early in cancers, dur-
ing the avascular phase of carcinoma in situ, CIS (Barathova
et al., 2008). There is reason to suspect that the most acidic
CIS are more prone to progress to local invasion. With intra-
ductal hyperplasia, IDH, cancer cells become increasingly distant
from the basement membrane and underlying vasculature. These
cells encounter an oxygen poor environment and, through a
Pasteur effect, undergo a metabolic switch toward a more gly-
colytic phenotype (Gatenby and Gillies, 2004). Consequently,
the proton (H+) concentration increases within the lumen due
to diffusion limitations and increased production of acid from
hypoxic-glycolytic cells, causing the interior of the lumen to
become highly acidic. Later on in carcinogenesis, the glycolytic
phenotype can become “hardwired” (i.e., the Warburg effect)
and this leads to the continued generation of metabolic acids,
even in well-oxygenated conditions (Figure 1). Adaptations to
this highly acidic microenvironment are critical steps in transi-
tion from an avascular pre-invasive tumor to a malignant invasive
carcinoma that has access to patent vasculature (Lee et al., 2008).
If acidosis contributes to the development of invasive carcinoma,
then an intervention that neutralizes pHe will either delay or
inhibit this last step in carcinogenesis. We have shown, using
31P-MRS of 3-aminopropylphosphanate, that administration of
oral buffers (200mM sodium bicarbonate) significantly raises the
pHe of xenograft tumors without altering pHi (Raghunand et al.,
1999). More importantly, buffer therapy has the ability to reduce
the formation of spontaneous and experimental MDA-MB-231
lung metastases (Robey et al., 2009) and suppress the formation
of spontaneous prostate tumors in the TRAMP prostate GEMM
(Ibrahim-Hashim et al., 2012).
The glycolytic byproducts, lactate and H+, challenge the
mechanisms to maintain intracellular pH (pHi) homeostasis.
Intracellular acidification has been shown to be cytotoxic through
induction of apoptosis (Gottlieb et al., 1996; Lagadic-Gossmann
et al., 2004). To overcome low pHi due to elevated rates of gly-
colysis, cancer cells employ a large redundancy of mechanisms to
remove acids in order to maintain physiological pHi. In response
to glycolytic acidosis, pHi can be be maintained via lactate and
H+ efflux by monocarboxylate transporters and Na-driven pro-
ton extrusion, respectively (Gillies, 2002; Gallagher et al., 2008).
As a consequence, the pH of the extracellular space of tumors
becomes acidic; forming a reversed pH gradient (pHe < pHi)
in comparison to normal physiological conditions (pHe > pHi)
(Figure 1) (Stubbs et al., 1994; Webb et al., 2011).
A reversed, acid-outside, pH gradient promotes cancer pro-
gression, via the relatively acidic pHe that induces migration and
invasion (Bradley et al., 2011; Hanahan and Weinberg, 2011).
Increased pHi by itself also has effects on cancer cell function
such as increased proliferation (Moolenaar et al., 1986), pro-
moting cell survival by limiting apoptosis, which is associated
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FIGURE 1 | Reversed extracellular and intracellular pH in cancer cells
compared to normal cells. Cancer cells have a reversed pH gradient
compared with normal differentiated cells that is cancer cells have a higher
pHi and a lower pHe than normal cells in acute acidosis conditions. The pHe
becomes even lower (∼6.7) in chronic acidosis. This disruption facilitates the
adaptive behaviors of cancer cells such as cytoskeleton remodeling and
directed migration, apoptosis evasion, extracellular matrix (ECM) remodeling,
invasion, and metastasis.
with intracellular acidification (Matsuyama and Reed, 2000), and
selective advantages of growth-factor independent proliferation.
In order to survive the dynamic nature of pH in tumors,
both cancerous and normal stromal cells require the ability to
sense minute pH changes and respond appropriately to main-
tain pHi homeostasis. One mechanism by which pH sensing
occurs is through post-translational protonation of amino acid
side chains, in particular the imidazole side chain of histidine
residues. Although under-represented in the human proteome
with ∼2% frequency (Webb et al., 2011), histidines are found in
critical regions of G-protein coupled receptors, GPCRs (OGR1
and GPR4), intracellular molecules involved in actin assembly
(Talin and Cofilin), membrane proton pumps and acid-sensing
ion channels, ASICs (Schonichen et al., 2013b). Protonation and
de-protonation has been experimentally shown to change pro-
tein structure and thus, alter protein-protein binding affinity,
change protein stability, modify protein function, and alter sub-
cellular localization (Schonichen et al., 2013b). Evolutionarily,
histidines must confer some selective advantage for cancers, as
15% of the 2000 identified somatic mutations in cancer involve
histidine subsitutions, with Arg-to-His being the most frequent
(Kan et al., 2010). The pH sensing role of histidines in cancer will
be discussed further in this review.
SECTION 1: THE INTRACELLULAR pH
Regulation of pH starts with changes in the expression or activity
of several plasma membrane molecules such as pumps and trans-
porters that facilitate H+ efflux to maintain the alkaline pHi and
the acidic pHe in tumor cells (Huber et al., 2010). These redun-
dant mechanisms of tumor pH regulation include: Carbonic
Anhydrases such as CA2, CA9, and CA12 (Barathova et al., 2008;
Supuran et al., 2010); V-ATPase (Hinton et al., 2009); Na+/HCO−3
co-transporters (Pouyssegur and Mechta-Grigoriou, 2006); the
Na+-driven Cl−/HCO−3 exchanger, SLC4A8 (Pouyssegur et al.,
2006); the monocarboxylate transporters: MCT1, MCT2, MCT3,
and MCT4 (Enerson and Drewes, 2003); Na+/H+ exchanger 1,
NHE1, which is also known as SLC9A1 (Amith and Fliegel, 2013);
and the anion exchangers AE1 and AE2, also known as SLC4A1
and SLC4A2 (Barneaud-Rocca et al., 2011) (Figure 2).
CARBONIC ANHYDRASES (CAs)
The CA family of proteins are metalloenzymes that catalyze the
conversion of carbon dioxide generated in high amounts as the
final product of oxidative phosphorylation and water to bicar-
bonate and protons. A primary function of CAs is to maintain
the intra- and extracellular acid–base balance. CAIX and CAXII
are transmembrane CAs that have been identified to play roles
in tumor progression and metastasis (Tafreshi et al., 2012; Ilie
et al., 2013). It has recently been shown that CAIX in colon
cancer and glioblastoma promotes tumor growth and necrosis
(McIntyre et al., 2012). As a transcriptional target of HIF1α, CAIX
expression is upregulated in hypoxic regions of tumors including
breast cancer (Tafreshi et al., 2012). CAXII is also overexpressed
in tumors and is associated with cancer progression. Although
CAXII and CAIX can be expressed in the same cells, their intra-
tumoral distributions are often different with more global and
more regional distributions, respectively (Tafreshi et al., 2012).
Intracellular CAs (e.g., CAII) will dehydrate metabolically pro-
duced bicarbonate into aqueous CO2 in a reaction consuming a
proton. By mass action, the CO2 is exported across the bilayer or
through aquaporins, where it is re-hydrated by CAIX or CAXII
to re-produce HCO−3 in a reaction producing an extracellular
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FIGURE 2 | Major pH regulators in a cancer cell. After glucose uptake by
specific transporters (GLUT1 and GLUT3), glucose is converted to pyruvate,
generating 2 ATP per glucose and proton. Based on Pasteur effect, in the
presence of oxygen, pyruvate is oxidized to HCO−3 , generating 36 additional
ATP per glucose; in the absence of oxygen pyruvate is reduced to lactate,
which is exported to extracellular space. However, as Warburg proposed
glycolysis is potent in cancer cells. Notably both processes produce
protons (H+), which cause acidification of the extracellular space. This
figure represents main proteins that regulate intracellular and extracellular
pH in tumors, including: monocarboxylate transporters (MCTs), which
transport lactic acid and other monocarboxylates formed by the glycolytic
degradation of glucose; the plasma membrane proton pump vacuolar
ATPase (V-ATPase); Na+/H+ exchangers (NHEs); anion exchangers (AEs);
carbonic anhydrases (CAII, CAIX, and CA XII); Na+/HCO−3 co-transporters
(NBCs), and HCO−3 -transporters (BTs).
proton. The HCO−3 can then diffuse out of the tumor, or re-enter
the cell via bicarbonate transporters or anion exchangers to main-
tain a more alkaline pHi (Xie et al., 2009; Swietach et al., 2010).
CAIX is an important facilitator of acid diffusion that its impor-
tance in regulating tumor pH has made it a potential target for
designing new therapeutics against cancer (Swietach et al., 2010).
HCO−3 TRANSPORTERS
These proteins are mainly clustered into three classes: electroneu-
tral Cl−/HCO−3 exchangers of the SLC4 family; the NBC family
of Na+/ HCO−3 co-transporters; and anion transporters of the
SLC26 family. Additionally, HCO−3 transport via aquaporins has
been reported (Cooper et al., 2002). These transporters facil-
itate the movement of HCO−3 ions across plasma membranes
to either acidify or alkalinize the pHi (Vilas et al., 2009). It
has been shown via functional assays that the Na+/ HCO−3 co-
transporter (NBCn1) is the predominant mechanism for acid
extrusion in breast carcinoma tissue when pHi levels are greater
than 6.6 (Boedtkjer et al., 2013). In fact, inhibition of NBCn1,
in NHE1 expressing cells, resulted in pHi acidification suggest-
ing that NBCn1 should garner further attention as a therapeutic
target (Boedtkjer and Aalkjaer, 2012; Boedtkjer et al., 2012).
NHE1
NHE1 is the most common isoform of the Na+/H+ exchanger
(NHE) family that is present in all mammalian cells. The NHEs
(NHE1-NHE7) are amongst the most active transporters in pHi
homeostasis and use the powerful sodium electrochemical gradi-
ent to extrude H+ if the cytosolic pH becomes too acidic. Notably,
there is a pH sensing site on the internal surface of the NHE that,
if protonated, activates transport. This “set-point” can be altered
by growth factor (e.g., EGF) activation. In cancer cells with their
high metabolic acid load, NHE1 hyperactively extrudes protons
into the extracellular space making it acidic. Particularly in breast
cancer, it has been suggested that upregulation of NHE1 activity
is a main factor for increased invasion and metastasis (Gatenby
and Gillies, 2008; Busco et al., 2010; Amith and Fliegel, 2013).
For example, it has been shown that CD44, which is a cell surface
glycoprotein, is localized at the invadopodia of an invasive breast
cancer cell line, MDA-MB-231 cells. CD44 stimulates NHE1
activity leading to invasion through the RhoA effector ROCK1
(Bourguignon et al., 2004). It has also been shown that RAC1 and
the RhoA–ROCK–PI3K pathway are involved in CD44-induced
cell invasion (Bourguignon et al., 2001). In cervical cancer, it has
been shown that NHE1 up-regulation by EGF is important for
cervical cancer cell invasiveness (Chiang et al., 2008). Hence, it
appears that signaling molecules can activate NHE1 leading to a
reversed pH gradient. Treating MDA-MB-231 cells with an NHE
inhibitor (cariporide) suppressed the invasive capability of this
highly metastatic breast cancer cell line (Lin et al., 2011a,b).
V-ATPase
Vacuolar ATPases pump protons out of the cytoplasm and into
intracellular vesicles, such as lysosomes in an ATP dependent
process (Horova et al., 2013) and these events are also altered in
cancer (Perez-Sayans et al., 2009a,b). Importantly, the activity of
these pumps is tightly coupled to endosome trafficking, suggest-
ing that they need not be resident at the plasma membrane to
exert their pH regulatory effects (Martinez-Zaguilan et al., 1999,
2013). Indeed, Glunde et al. (2003, 2005) and Cardelli (Steffan
et al., 2009) have both shown that low pH induces the turnover of
endosomal-lysosomal compartments with the extracellular space,
which could be an indirect mechanism for V-ATPase mediated
extrusion of H+ from the cytosol. Saw et al. recently showed
that high-metastatic B16-F10 melanoma cells overexpress the a3
isoform V-ATPase compared to the low-metastatic B16 parental
cells and V-ATPase inhibitors reduced bone metastasis (Saw et al.,
2011).
MONOCARBOXYLATE TRANSPORTER (MCTs)
MCTs transport mono-carboxylic acids (such as lactate, pyru-
vate, and ketone bodies) into and out of cells across plasma and
mitochondrial membranes. The MCT family is composed of 14
members with similar topology and can be found expressed in
a wide range of tissues. Only 4 isoforms (MCT1–MCT4) have
been functionally characterized as proton-linked monocarboxy-
late transporters (Morris and Felmlee, 2008; Halestrap, 2012;
Halestrap andWilson, 2012). This is critical as MCTs (MCT1 and
MCT4) are routinely overexpressed in tumors primarily regulat-
ing the efflux of lactate and protons as byproducts of glycolysis
from intracellular to extracellular space in order to maintain
physiological pHi thus, contributing to extracellular acidosis.
High expression levels of these transporters have been linked to
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poor prognosis and disease progression in colorectal, ovarian,
gastric, and breast carcinomas (Pinheiro et al., 2009a,b, 2010;
Chen et al., 2010).
So far, we have focused on tumor hypoxia and efflux mecha-
nisms by which cancer cells regulate pHi on account of increased
glycolysis. One mechanism discussed was the outward flux of
lactic acid by MCT1/4. We must appreciate, however, that it is
not uncommon to observe well oxygenated and nutrient rich
tissue coexisting with hypoxic and carbon poor tissue (Gatenby
et al., 2013). Although these regions are metabolically distinct,
it is hypothesized that carbon symbiosis occurs between gly-
colytic and oxidative compartments to promote tumor growth
wherein hypoxic tissue mostly consumes glucose and oxygen
rich tissue consumes the glycolytic byproduct, lactate (Nakajima
and Van Houten, 2013). Sonveaux et al. have proposed that this
transpires through specific intratumoral MCT1 expression pat-
terns that are environmentally regulated (Sonveaux et al., 2008).
Using human cervical and colon xenograft tumor models, MCT1
expression was highest in well-oxygenated tissue (CD31 positive)
with little to no detectable expression in hypoxic (Pimonidazole
positive) regions. The authors show that oxygenated tissue pro-
motes the inward flux of lactate via MCT1 to fuel the TCA
cycle and that in vivo inhibition of MCT1 with α-cyano-4-
hydroxycinnamate limited tumor growth. Sonveaux hypothesized
that the anti-tumor effect was a result of a metabolic switch from
lactate-fueled respiration to glycolysis in oxygenated tissue fur-
ther reducing the carbon source for hypoxic tissue (Sonveaux
et al., 2008).
Similar observations were made by Koukourakis et al. in col-
orectal adenocarcinoma (Koukourakis et al., 2006). Using patient
tissue, tumor, and stromal compartments were histologically and
thus, metabolically distinguishable based on MCT and glucose
transporter expression patterns. Colorectal adenocarcinoma was
shown to express high glucose uptake (GLUT1) and lactate efflux
(MCT1) proteins in respect to tumor associated stromal cells that
expressed low glucose uptake and high lactate influx (MCT1 and
MCT2) proteins driving lactate oxidation (Koukourakis et al.,
2006). Similar cancer-stromal cell metabolic collaboration has
also been proposed by Lisanti’s group, who has observed MCT1
in tumors, and MCT4 in stroma, prompting them to characterize
this as a “reverse Warburg Effect” (Witkiewicz et al., 2012). These
examples highlight alternative roles for MCTs in addition to regu-
lating pHi homeostasis and that inhibition of MCTs may disrupt
tumor metabolism homeostasis providing therapeutic benefit.
pH-SENSING PROTEINS THAT REGULATE ACTIN ASSEMBLY
PLAY ROLE IN CANCER CELL MIGRATION
Although the effects of pH on intracellular processes are ubiq-
uitous, one of the major pH-sensitive systems in the cells is the
actin cytoskeleton. The assembly of globular (G-actin) to fila-
mentous (F-actin) and higher structures as well as the reverse
process of filament disassembly play different roles in cancer cell
processes and behaviors such as vesicle trafficking, contraction,
migration, invasion, and metastasis. De novo actin assembly in
mammalian cells requires pHi > 7.2 (Webb et al., 2011) and
changes (of 0.3–0.4 units) in pHi induce dramatic differences in
actin filament assemblies and architectures. These observations
suggest that disruption of pHi in either direction can negatively
impact themobility of cancer cells and eventually affect metastasis
(Hansen and Kwiatkowski, 2013).
ADF/COFILIN
Polymerizing actin filaments, which are essential for migra-
tory cells, requires the activity of the actin-severing protein,
cofilin (Sidani et al., 2007). The actin depolymerizing factor
(ADF)/cofilin family, including ADF, non-muscle cofilin-1 and
muscle cofilin-2, are pH sensors that sever and nucleate actin fil-
aments (Bravo-Cordero et al., 2013). In migrating cells, cofilin
increases filament disassembly at one end of actin networks and
generates free ends for nucleation and assembly at the plasma
membrane (Bernstein and Bamburg, 2010). The severing activ-
ity of cofilin requires (de)phosphorylation of an N-terminal
serine residue and (de-) protonation of a C-terminal histidine
residue. Overactivity of cofilin requires both the dephospho-
rylation of the serine and the deprotonation of histidine to
occur. Although cofilin is not directly pH regulated, its bind-
ing to Phosphatidylinositol (Lope-Piedrafita et al., 2008) in the
plasma membrane is pH-dependent and regulates its activity.
Dissociation from membrane PI at more alkaline pHi increases
cofilin activity (Frantz et al., 2008).
ADF is extremely pH sensitive and its regulation occurs
through a pH-dependent salt-bridge at the F site between His133
and Asp98 of β-strand4. The salt-bridge is stable at slightly acidic
conditions but broke at alkaline pH, leading to partial unfolding
of the F site and presumably increases actin-binding activity of
ADF. Cofilin and ADF have differential pH sensitivity because
they bind to actin in different ways (Schonichen et al., 2013b).
Cofilin binding to cortactin in invadopodia (i.e., invasive plas-
mamembrane protrusions of cancer cells) sequesters inactive
cofilin at the distal membrane of invadopodia and its binding
affinity decreases as pHi increases (Magalhaes et al., 2011).
TALIN
Dynamic remodeling of actin filaments at focal adhesion sites is
also pHi sensitive. This regulation is critical at the leading edge of
migrating cells where increased pHi is needed (Stock and Schwab,
2009). It has been shown that pHi is higher at the leading edge
of migrating cells and it is actually highest at the focal adhe-
sions (Martin et al., 2011; Ludwig et al., 2013). The effect of pHi
on focal adhesion is mediated partly by talin binding to F-actin,
which binds actin filaments to focal adhesions. The N-terminal
domain of talin that binds β-subunits of integrin receptors at
the cytosolic side contains a pH-insensitive F-actin-binding site
(Critchley, 2009). On the other hand, the C-terminal module that
also binds F-actin is pH dependent (Critchley, 2009). So, talin
is a pH-sensor whose binding to actin filaments decreases at a
pH> 7.2, permitting faster focal adhesion turnover and increased
migration (Srivastava et al., 2008). Protonation of amino acids
in a pH-sensor region causes conformational changes at distant
actin-binding sites and allosterically regulates the actin-binding
domain of talin (Srivastava et al., 2008; Critchley, 2009).
GUANINE NUCLEOTIDE EXCHANGE FACTORS
Some guanine nucleotide exchange factors (GEFs) contain PH
(plextrin-homology) domains that show binding specificity to
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membrane phosphoinositides. One example is Dbs, a Dbl fam-
ily Rho GEF that activates the Rho GTPase Cdc42 at the leading
edge of migrating cells that leads to a polarized movement. Dbs
contains a PH domain that binds to PIP2 with higher affinity at
lower pH (Frantz et al., 2007). However, there are some other Dbl
family Rho GEFs, such as intersectin, that contain a similar PH
domain but with pH-independent binding to PIP2. Most of Dbs
but not all (such as intersectin) have a histidine (His843) at the
PIP2-binding site of the pH-sensitive domain (Frantz et al., 2007),
similar to pH-dependent binding of cofilin to PIP2.
Arf GTPases are localized at acidic endosomes and regu-
late endosomal trafficking and actin dynamics (Donaldson and
Jackson, 2011). As an example, the pH domain of Grp1, a GEF
for Arf GTPases, has pH-dependent binding to phosphoinosi-
tides. In contrast to Dbs, Grp1 binds PIP3 instead of PIP2 at
endosomal membranes, with a higher binding affinity at lower
pH (He et al., 2008, 2011). Grp1’s increased binding affinity is
because of protonation of His355 located in the loop between
β6 and β7 that interacts with the phosphate group 4 of inositol
1,3,4,5-tetrakisphosphate (IP4) (Schonichen et al., 2013b).
It has been shown recently that phosphoinositide-binding
domains are common in physiological pH sensing proteins such
as Fab1p, YOTB, Vac1p, and EEA1 (Lee et al., 2005), ENTH
and ANTH. They all show increased phosphoinositide binding
affinities at pH values below neutral ∼7.2. A common feature
of these domains is that they all contain at least one histi-
dine for stereospecific phosphoinositide recognition. Although
not experimentally shown yet, proteins containing these domains
most probably have membrane localization and pH dependent
activity and, if associated with the actin cytoskeleton, could reg-
ulate the actin filament dynamics at focal adhesions (Schonichen
et al., 2013a,b). Understanding the significance of pH-dependent
histidine switches for phosphoinositide can help to understand
the role of pH-regulated metastasis.
SECTION 2. THE EXTRACELLULAR pH
A consequence of pH homeostasis in the face of a high metabolic
acid load is the transport of H+ into the interstitial space. In
tumors that are metabolically active, estimates of the interstitial
space (Kep) from dynamic contrast enhanced (DCE) MRI, range
from 6 to 12%. Hence there is a 10-fold greater acid load on the
extracellular environment compared to intracellular, and this is
generally relieved via diffusive transport of mobile buffers from
the source, i.e., cells, to the sink, i.e., the vasculature (Schornack
and Gillies, 2003). If these diffusion path lengths become long,
e.g., greater than 50 microns, then the pHe becomes profoundly
acidic. Such conditions are not only encountered in cancer, but in
other pathological states, such as ischemia, or following trauma,
and mammalian cells have evolved (or retained) sophisticated
mechanisms to sense their environmental pH and adjust their
behaviors accordingly.
pH SENSORS IN PLASMAMEMBRANE
Plasma membrane pH sensors in cells are categorized mainly as
G-protein coupled receptors (GPCRs) and non-GPCR sensors.
Proton-sensing GPCR expression varies by cell type. This sub-
family of proton-sensing GPCRs includes GPR4, OGR1 (GPR68),
TDAG8 (GPR65), andG2A (GPR132), which have also been iden-
tified as receptors for lysolipids; sphingosylphosphorylcholine
(SPC), lysophosphatidylcholine (LPC), and psychosine (galac-
tosylsphingosine) (Ludwig et al., 2003). OGR1 is coupled with
the PLC/Ca2+ signaling pathway through Gq/11 proteins. On the
other hand, GPR4 and TDAG8 are coupled with the cAMP signal-
ing pathways via Gs. It has recently been observed that activation
of TDAG8 with acid pH induces down regulation of c-myc in
lymphoma cells (Li et al., 2013). Discovery of the proton-sensing
ability of transient receptor potential V1 (TRPV1), a calcium-
channel also known as the capsaicin receptor and the vanilloid
receptor 1, was a breakthrough in the field of proton-sensing
mechanisms, because it showed that non-GPCR proteins can also
sense pH (Tomura et al., 2010). Another family of non-GPCR sen-
sors is the acid-sensitive ion channels (ASICs), which include 7
proteins from 4 genes. It has been shown that ASIC1 and ASIC2
are expressed in the central nervous system and are important in
pain processing (Wemmie et al., 2013). Understanding pH sensors
will provide insight into the molecular basis of pH-dependent
phenomena that may help us to understand cancer cell behavior
and eventually identify new diagnostics and therapeutics.
OGR1
Ovarian cancer G protein-coupled receptor 1 (OGR1), previ-
ously described as sphingosylphosphorylcholine receptor, is a
proton sensing receptor that stimulates inositol phosphate forma-
tion. It is inactive at pHe ∼7.8 and fully activated at pHe ∼6.8
(Ludwig et al., 2003). Using a computational model, Ludwig et
al demonstrated that the ability of OGR1 to sense pH resides
within histidines located in the extracellular loops. They pro-
posed that acidic pH destabilizes the hydrogen bonds of these
histidines and switches the receptor to its active conformation.
They also predicted five histidines (H17, H20, H84, H169, and
H269) are key players and demonstrated that substituting each
histidine with phenylalanine reduces the proton-sensing ability of
OGR1 (Ludwig et al., 2003)
It has recently been shown that OGR1 deficiency (OGR1−/−)
in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP)
model reduced tumor formation. The same group also
showed similar results in murine melanoma cell xenografts in
OGR1−/−mice (Yan et al., 2012a,b). OGR1 expression is lower
in human metastatic compared with primary prostate cancer tis-
sue. In light of this observation, OGR1 has been characterized as
a new metastasis suppressor gene in prostate cancer cells (Singh
et al., 2007). This observation also extends to breast, where Li et
al recently showed that OGR1 inhibits cell migration through a
Gα12/13 -Rho-Rac1 signaling pathway in MCF7 breast cells (Li
et al., 2013). These results suggest that OGR1 may act as a tumor
and metastasis suppressor. However, the role of pH and proton-
activated signaling in this protein and their relationship to this
type of anti-tumor behavior needs to be investigated further.
Interestingly, OGR1 was also shown to be overexpressed in
human medulloblastoma, a cancer of neuronal precursor cells.
Activation of OGR1 in human medulloblastoma cell line trig-
gers activation of the ERK signaling pathway through proton-
mediated Ca2+ release in the cytoplasm (Huang et al., 2008).
This implies how extracellular acidification can promote cell
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survival in medulloblastoma. This important finding demon-
strates a tumor promoting mechanism, different than the anti-
tumor mechanism previously described in prostate cancer and
melanoma. Additionally, they demonstrated that only prolifer-
ating cells have the ability to translate an acidic pHe into gene
transcription, suggesting that the acidic microenvironment pro-
vides a survival advantage to proliferating cancer cells over non-
transformed cells (Glitsch, 2011). In contrast, Yuan et al. have also
recently shown that OGR1-mediated [Ca2+] elevation induced
apoptosis by activation of calcium-sensitive proteases and their
downstream signaling molecules such as Bid, Bax, and caspase-3
in rat endplate chondrocytes (Yuan et al., 2013). Taken together,
all these observations imply that transduction of the acid-sensing
signal is highly context-dependent, leads to various phenotypes,
and depends on the cell-specific genetic history and lineage.
GPR4
G-protein coupled receptor 4 (GPR4), a close relative of OGR1,
also responds to pH changes, but elicits cyclic AMP formation
and accumulation. GPR4 plays its pH-sensing role through the
G12/13-protein/Rho, the Gq/PLC, and the Gs-protein/cAMP sig-
naling pathways (Liu et al., 2010). Acid-induced GPR4 activates
RhoA, stimulating the formation of actin stress fibers (Castellone
et al., 2011). GPR4 is overexpressed in breast, ovarian, colon, liver,
and kidney tumors at the mRNA level (Sin et al., 2004).
Osteosarcoma cells and primary human osteoblast precur-
sors exhibit strong pH-dependent inositol phosphate formation
and constitutively express GPR4 at their membranes. Tumor
growth in GPR4−/−mice is abrogated, because of reduced angio-
genesis, suggesting that acidic pH-stimulated GPR4 may regu-
late endothelial cell growth (Wyder et al., 2011). Some GPR4
inhibitors are under development as antiangiogenesis therapeu-
tics (PCT/EP07/63899). Buffer therapy, described above, might
also lead to deprotonation and hence, deactivation of GPR4.
Combination therapy using buffer or GPR4 inhibitors also
might be considered as a possible therapy against primary and
metastatic tumors.
T-CELL DEATH-ASSOCIATED GENE 8 (TDAG8)
TDAG8 is a pHe-sensing GPCR that is overexpressed in differ-
ent tumor types and cancer cell lines that also might play role in
immune response of cancer cells (Ishii et al., 2005). TDAG8, also
known as GPR65, was originally identified as an orphan GPCR
in apoptotic thymocytes. It was later demonstrated to func-
tion as a pHe sensor that responds to extracellular acidification
through Gs, thus, increasing cAMP (Radu et al., 2005). TDAG8
is overexpressed in kidney, colon and ovarian tumors (Sin et al.,
2004). TDAG8 can also mediate acid-stimulated cancer bone pain
through PKA signaling (Hang et al., 2012). Overexpressed TDAG8
at the cell membrane protects tumor cells against extracellu-
lar acidosis and can accelerate tumor development and shRNA
knockdown of endogenous TDAG8 attenuates cancer cell survival
in acidic media (Ihara et al., 2010). A mechanism for TDAG8 in
cancer cells in acidic environment has been proposed wherein cell
growth is related to TDAG8-mediated PKA and ERK activation
(Figure 3). Overexpression of TDAG8 in NIH3T3 induces differ-
ent types of oncogenic phenotypes such as rapid proliferation,
FIGURE 3 | Cancer cells express proton-sensing GPCRs such as GPR4,
TDAG8, and OGR1 to regulate their tumorigenesis and invasion.
TDAG8 and OGR1 sense extracellular protons, leading to activation of the
cAMP signaling pathway. OGR1 is usually coupled with the PLC/Ca2+
pathway through Gq/11 proteins and GPR4 and TDAG8 are coupled with the
adenylyl cyclase/cAMP pathway through Gs proteins in the cells to PKA and
ERK signaling pathway that play pivotal roles in cancer progression.
refractile cell shape, foci formation and tolerance to low serum-
conditioned media (Sin et al., 2004). Acid-activated TDAG8 can
also stimulate RhoA, actin rearrangement, and stress fiber forma-
tion (Ishii et al., 2005).
ACID-SENSITIVE ION CHANNELS (ASICs)
ASICs are voltage-independent ion channels that are mainly
expressed in peripheral sensory and central nervous system neu-
rons. They are acid responsive and permeable to cations. They
are also modulated by alkalosis and pHi and might play a role
of mechanosensation in neurons (Wemmie et al., 2013). These
proton-gated cation-selective channels are mostly permeable to
Na+ ions and belong to the degenerin/epithelial Na+ channel
(DEG/ENaC) superfamily (Jasti et al., 2007). There are seven sub-
units of ASICs encoded by four different genes: ASIC1a, ASIC1b1,
ASIC1b2, ASIC 2a, ASIC 2b, ASIC 3, and ASIC 4, amongst them
1a, 2a, 2b, and 3 subunits are present in CNS neurons. The low-
resolution crystal structure of the chicken ASIC1a at normal and
low pH was determined in 2007 and illustrated that functional
ASICs are trimeric assemblies (Jasti et al., 2007) (Figure 3). Each
ASIC subunit consists of two transmembrane domains (TM1 and
TM2) connected with a large extracellular loop that is cysteine
rich. ASIC1a and heteromeric ASIC1a/2b channels are permeable
to Ca2+ and can lead to an accumulation of intracellular Ca2+
inside neurons (Sherwood and Askwith, 2008). However, it’s been
shown that acidosis induced Ca2+ accumulation is not only due
to the activation of ASIC1a and ASIC1a/2 channels but also could
be due to activity of voltage-gated Ca2+ channels and/or release
of Ca2+ from intracellular pools such as sarcoplasmic membranes
in cancer cells (Leanza et al., 2013).
ASICs have different roles in peripheral neurons and CNS. In
the periphery, it is postulated that ASICs are involved in noci-
ception and mechano-sensation, (Sherwood et al., 2012); and
in the CNS, different ASICs play different roles; as ASIC1a is
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involved in synaptic plasticity, learning/memory and fear condi-
tioning; and ASIC2a is required for the maintenance of retinal
integrity and survival of neurons in global ischemia. It has also
been described that activation of Ca2+-permeable ASIC1a and
ASIC1a/2b proteins are involved in acidosis-mediated neuronal
degeneration (Pignataro et al., 2011). There is some evidence
that ASICs can also play role in cancer progression. ASIC1 and
ASIC2 have effects on the growth and migration of glioblas-
toma cells (Berdiev et al., 2003). Berdiev et al. demonstrated
that in grade IV gliomas, glioma cation current is mediated by
mixed ASIC1, ASIC2 and inhibition of this conductance decreases
glioma growth and cell migration. It has also been shown that
knockdown of ASIC1 and ENaC inhibits glioblastoma cell migra-
tion (Kapoor et al., 2009). In contrast to ASIC1, increasing surface
expression of ASIC2 suppresses the proliferation andmigration of
GBM cells (Vila-Carriles et al., 2006).
Recently Duan et al also showed that ASIC1 gene deletion
suppressed brain derived neurotrophic factor (BDNF) in mice.
The BDNF/TrkB pathway enhances ASIC1a ion activity via the
phosphoinositide 3-kinase (PI3K)-protein kinase B (PKB/Akt)
cascade. PKB/Akt phosphorylates cytoplasmic Ser-25 residue of
ASIC1a, resulting in increased trafficking activity and surface
expression. By this they proposed a new mechanism for pain
hypersensitivity (Duan et al., 2012). ASICs’ activity and contri-
bution toward bone-related pain make it a possible target for
buffer therapy to neutralize metastatic acid (Nagae et al., 2007;
Sluka et al., 2009). In continuation of this observation, a new
trial is currently recruiting late-stage cancer patients to further
test the ability of buffer therapy to reduce cancer related pain
(NCT01846429: Oral Bicarbonate as Adjuvant for Pain Reduction
in PatientsWith Tumor Related Pain, sponsored by H. LeeMoffitt
Cancer Center and Research Institute).
TRANSIENT RECEPTOR POTENTIAL CHANNEL VANILLOID SUBFAMILY
1 (TRPV1)
TRPV1 channels are cation channels with a high selectivity for
Ca2+. Extracellular acidity activates and opens TRPV1 channels
in the absence of other stimuli. TRPV1 is not the only proton
sensing protein in the family of TRPVs as it has been shown
that TRPV4 is also activated by protons in the absence of extra-
cellular Ca2+ (Holzer, 2009). TRPV1 is involved in nociception
and has been particularly investigated in metastatic bone pain
(Kato and Morita, 2013). It has also been reported that the
acidic microenvironment of the bone cancer is responsible for
the TRPV1-mediated pain. Neurons near metastatic lesions sense
the high proton concentration of the tumor environment using
these proton-sensing ion channels (Yoneda et al., 2011). TRPV1
is expressed and upregulated in different cancers such as human
prostate cancer cells and its activation induces Akt and ERK
activation suggesting that TRPV1 activation promotes prostate
cancer progression. In contrast, in other reports, activation of
TRPV1 leads to induction of apoptosis in cancer cells (Bode and
Dong, 2009; Kalogris et al., 2010).
CONCLUSIONS
Historically, the effect of extracellular acidosis had been thought
to be transduced via acidification of the pHi. However, cells in
general, and cancer cells in particular, have redundant and highly
active proton exporting mechanisms to maintain the pHi within
tight bounds (7.2–7.4) even in the presence of severe extracel-
lular acidosis. An alternative view has emerged over the past
decade that the extracellular surface of mammalian cells contains
a number of acid-sensors, mediated primarily through expres-
sion of surface-accessible histidines. These receptors transduce
signals to the cytoplasm and nucleus mediated by cAMP, Ca2+,
and K+, to affect cellular survival, proliferation signaling and
cytoskeletal remodeling. Clearly, this is an active and important
area of basic research, with implications for normal physiology
and pathophysiology.
It is somewhat surprising that there is little evidence for direct
mechanistic connectivity between acid sensors and acid trans-
porters. This is particularly true in cancer cells that survive and
proliferate in chronically acidic conditions. Acid-sensing proteins
affect intracellular signal transduction pathways and gene expres-
sion, yet surprisingly none of these appear to directly activate
proton extrusion mechanisms. This might suggest that either
a low pHe does not contribute greatly to the intracellular acid
load or there is a connection that has not yet been elaborated.
One proof for the first hypothesis would be that at a nominal
membrane potential of −58mV, the Nernst equation predicts
that the equilibrium pHi should be 1.0 pH unit below that of
pHe. With a reversed pH gradient there is a large proton motive
force driving H+ into cells. However, even though the perme-
ability of H+ to lipid bilayers is orders of magnitude higher
than alkali ions, it is still quite low, between 10−5–10−7 cm s
(Nichols and Deamer, 1980; Gutknecht, 1984) implying that the
inward directed passive flux of H+ across bilayers is much lower
than the metabolically produced or outwardly transported flux
of H+. Consequently, the effect of acidic pHe on the pHi is
indirect and thus, it may not be physiologically necessary to cou-
ple H+ sensing to H+ extrusion. Another hypothesis would be
that the effect of acidic pHe on the pHi is mediated by highly
regulated and coordinated families of carriers. These are most
probably electroneutral HCO−3 transporters since the electoneu-
tral transporters react only to the concentration gradients and not
the electromotive force. Uncovering mechanisms of pHe medi-
ation by pHi or vice versa could be an interesting avenue of
future investigation in the field of pH sensing and regulation in
cancer.
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